Co-morbidity in rheumatoid arthritis
- 6 August 2003
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 17 (5) , 729-752
- https://doi.org/10.1016/s1521-6942(03)00041-x
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug AdministrationArthritis & Rheumatism, 2002
- Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral DensityNew England Journal of Medicine, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Risk factors for coronary heart disease and acute-phase proteins. A population-based studyEuropean Heart Journal, 1999
- Rheumatoid arthritis and lymphatic cancerEuropean Journal Of Cancer, 1996
- Rheumatoid arthritis and cancer riskEuropean Journal Of Cancer, 1996
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994
- CD5+ B cells in autoimmune disease and lymphoid malignancyClinical Immunology and Immunopathology, 1991
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Association of Adrenocorticosteroid Therapy and Peptic-Ulcer DiseaseNew England Journal of Medicine, 1983